NEW YORK, March 21 – With genomics stocks continuing to drop, the possibility for potential takeover bids is increasing, analysts said Wednesday. 

“I definitely think there is an opportunity to acquire good biotech companies with good technology and balance sheets,” said Andrew Scott, an analyst at M. H. Meyerson in New York.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.